Valuation: Bioneer Corporation

Market Cap 165B 113M 99.04M 92.1M 84.52M 159M 10.86B 161M 1.09B 427M 5.34B 423M 414M 18.46B P/E 2024
-23.6x
P/E 2025 -117x
Enterprise Value 179B 122M 107M 99.88M 91.65M 172M 11.78B 175M 1.19B 463M 5.79B 459M 449M 20.02B EV / Sales 2024
1.59x
EV / Sales 2025 1.04x
Free-Float
82.04%
Yield 2024 *
-
Yield 2025 -
1 day-0.31%
1 week+2.90%
Current month-6.73%
1 month-3.48%
3 months-41.84%
6 months-49.12%
Current year-49.96%
1 week 5,870
Extreme 5870
6,610
1 month 5,870
Extreme 5870
7,150
Current year 5,870
Extreme 5870
14,210
1 year 5,870
Extreme 5870
15,870
3 years 5,870
Extreme 5870
47,700
5 years 5,870
Extreme 5870
98,800
10 years 4,355
Extreme 4355
98,800
Manager TitleAgeSince
Chief Executive Officer 64 1992-07-31
Corporate Officer/Principal 62 2024-03-27
Corporate Officer/Principal 51 2025-03-30
Director TitleAgeSince
Director/Board Member 64 2011-02-17
Director/Board Member 61 1997-04-30
Director/Board Member 63 2000-01-31
Date Insider Type Main position Quantity % Market Cap.
6/12/25 Fiscal year

Director

2,625 0.0102%
3/3/25 Buy

Chief Executive Officer

3,000 0.0116%
1/22/25 Buy 1,579 0.0061%
Change 5-day change 1-year change 3-year change Capi.($)
-0.31%+2.90%-58.97%-85.16% 113M
+0.93%+6.97%+59.60%+68.35% 57.28B
-1.92%+6.03%+40.64%+83.42% 54.99B
-0.46%-1.29%+2.86%+428.78% 23.18B
-2.97%-2.35%-22.53%-16.40% 22.59B
-0.36%+5.73%+24.13%-6.24% 20.46B
-1.34%+0.51%+26.03%-29.41% 17.56B
-1.44%+5.67%+38.77%+504.71% 15.67B
-1.30%-5.02%+170.77%+291.37% 14.46B
-0.50%-0.98%+21.43%+180.07% 13.92B
Average -0.97%+1.63%+30.27%+141.95% 24.02B
Weighted average by Cap. -0.87%+2.10%+39.65%+133.39%

Financials

2024 2025
Net sales 294B 201M 177M 164M 151M 283M 19.39B 288M 1.95B 763M 9.53B 756M 739M 32.95B 330B 226M 199M 185M 169M 318M 21.77B 323M 2.19B 857M 10.7B 849M 830M 37B
Net income -20.58B -14.1M -12.38M -11.51M -10.56M -19.85M -1.36B -20.16M -137M -53.41M -667M -52.91M -51.77M -2.31B -2.81B -1.93M -1.69M -1.57M -1.44M -2.71M -186M -2.75M -18.68M -7.3M -91.2M -7.23M -7.08M -315M
Net Debt -20.54B -14.06M -12.35M -11.49M -10.54M -19.81M -1.35B -20.11M -136M -53.29M -666M -52.8M -51.66M -2.3B 13.9B 9.52M 8.36M 7.77M 7.13M 13.4M 916M 13.61M 92.31M 36.06M 451M 35.73M 34.96M 1.56B
Logo Bioneer Corporation
Bioneer Corp is a Korea-based company engaged in the biotechnology business. The Company mainly operates genetic research, molecular diagnostics, probiotics, and ribonucleic acid interference (RNAi) new drug development businesses. The Company mainly provides services such as gene analysis and synthesis, gene expression, and protein expression and purification. The Company’s products include body fat-reducing lactic acid bacteria in probiotics field, and basic materials, reagents, kits, gene extraction, amplification, quantitative analysis equipment, molecular diagnosis equipment for genetic research and molecular diagnosis used in molecular diagnosis field. The Company also provides laboratory equipment, single products, and laboratory consumables used in biotech research.
Employees
392
Date Price Change Volume
26-07-24 ₩6,380.00 -0.31% 44,605
26-07-23 ₩6,400.00 +6.31% 62,558
26-07-22 ₩6,020.00 -0.50% 41,283
26-07-21 ₩6,050.00 -0.66% 65,986
26-07-20 ₩6,090.00 -1.77% 57,345
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A064550 Stock